
Masoud H. Noori
Examiner (ID: 3784, Phone: (571)272-2185 , Office: P/2855 )
| Most Active Art Unit | 2855 |
| Art Unit(s) | 2855, 2214, 2856, 2616 |
| Total Applications | 3955 |
| Issued Applications | 3448 |
| Pending Applications | 170 |
| Abandoned Applications | 350 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16435599
[patent_doc_number] => 20200352924
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-12
[patent_title] => CHARGED ION CHANNEL BLOCKERS AND METHODS FOR USE
[patent_app_type] => utility
[patent_app_number] => 16/936556
[patent_app_country] => US
[patent_app_date] => 2020-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14609
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16936556
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/936556 | Charged ion channel blockers and methods for use | Jul 22, 2020 | Issued |
Array
(
[id] => 17850433
[patent_doc_number] => 20220280474
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => KV1.3 ANTAGONISTS FOR USE IN THE TREATMENT OF CHRONIC AND ACUTE PAIN
[patent_app_type] => utility
[patent_app_number] => 17/631155
[patent_app_country] => US
[patent_app_date] => 2020-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9857
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17631155
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/631155 | KV1.3 ANTAGONISTS FOR USE IN THE TREATMENT OF CHRONIC AND ACUTE PAIN | Jul 21, 2020 | Pending |
Array
(
[id] => 17865282
[patent_doc_number] => 20220288017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => NITENIN ANALOGUE COMPOUNDS AND THEIR USE IN THE TREATMENT OF CHRONIC AND ACUTE PAIN
[patent_app_type] => utility
[patent_app_number] => 17/631135
[patent_app_country] => US
[patent_app_date] => 2020-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13891
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17631135
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/631135 | Nitenin analogue compounds and their use in the treatment of chronic and acute pain | Jul 21, 2020 | Issued |
Array
(
[id] => 17851824
[patent_doc_number] => 20220281866
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => 5,8-DISUBSTITUTED-[1,2,4]TRIAZOLO[1,5-A]PYRIDINYL AND 5,8-DISUBSTITUTED-IMIDAZO[1,2-A]PYRIDINE DERIVATIVES USEFUL AS INHIBITORS OF ENTEROPEPTIDASE
[patent_app_type] => utility
[patent_app_number] => 17/626830
[patent_app_country] => US
[patent_app_date] => 2020-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43174
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17626830
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/626830 | 5,8-DISUBSTITUTED-[1,2,4]TRIAZOLO[1,5-A]PYRIDINYL AND 5,8-DISUBSTITUTED-IMIDAZO[1,2-A]PYRIDINE DERIVATIVES USEFUL AS INHIBITORS OF ENTEROPEPTIDASE | Jul 16, 2020 | Pending |
Array
(
[id] => 19026294
[patent_doc_number] => 11925634
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-12
[patent_title] => Use of koumine in preparation of medicament for treatment of inflammatory bowel disease
[patent_app_type] => utility
[patent_app_number] => 17/637491
[patent_app_country] => US
[patent_app_date] => 2020-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 5218
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17637491
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/637491 | Use of koumine in preparation of medicament for treatment of inflammatory bowel disease | Jul 9, 2020 | Issued |
Array
(
[id] => 16877930
[patent_doc_number] => 11028063
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-08
[patent_title] => Processes for producing 2,5-furandicarboxylic acid and derivatives thereof and polymers made therefrom
[patent_app_type] => utility
[patent_app_number] => 16/946850
[patent_app_country] => US
[patent_app_date] => 2020-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 14985
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 235
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16946850
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/946850 | Processes for producing 2,5-furandicarboxylic acid and derivatives thereof and polymers made therefrom | Jul 8, 2020 | Issued |
Array
(
[id] => 17791961
[patent_doc_number] => 20220251052
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => IMPROVED PROCESS FOR THE PREPARATION OF 2-(3,5-DICHLOROPHENYL)-1,3-BENZOXAZOLE-6-CARBOXYLIC ACID OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS AND POLYMORPHS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/624591
[patent_app_country] => US
[patent_app_date] => 2020-07-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5363
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17624591
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/624591 | IMPROVED PROCESS FOR THE PREPARATION OF 2-(3,5-DICHLOROPHENYL)-1,3-BENZOXAZOLE-6-CARBOXYLIC ACID OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS AND POLYMORPHS THEREOF | Jul 3, 2020 | Pending |
Array
(
[id] => 19969627
[patent_doc_number] => 12338218
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-24
[patent_title] => Crystal form of benzimidazole-2-one compound, solvate thereof, crystal form of solvate thereof, and preparation method thereof
[patent_app_type] => utility
[patent_app_number] => 17/624462
[patent_app_country] => US
[patent_app_date] => 2020-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 3022
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17624462
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/624462 | Crystal form of benzimidazole-2-one compound, solvate thereof, crystal form of solvate thereof, and preparation method thereof | Jul 2, 2020 | Issued |
Array
(
[id] => 18036115
[patent_doc_number] => 20220380330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => Process for Producing Substituted Lactones
[patent_app_type] => utility
[patent_app_number] => 17/597889
[patent_app_country] => US
[patent_app_date] => 2020-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9011
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17597889
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/597889 | Process for Producing Substituted Lactones | Jul 1, 2020 | Abandoned |
Array
(
[id] => 16649929
[patent_doc_number] => 10927091
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-23
[patent_title] => Continuous carbonylation processes
[patent_app_type] => utility
[patent_app_number] => 16/919644
[patent_app_country] => US
[patent_app_date] => 2020-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19165
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 348
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16919644
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/919644 | Continuous carbonylation processes | Jul 1, 2020 | Issued |
Array
(
[id] => 19012961
[patent_doc_number] => 11919876
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-05
[patent_title] => Process and system to make olefin epoxides
[patent_app_type] => utility
[patent_app_number] => 17/597888
[patent_app_country] => US
[patent_app_date] => 2020-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6782
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17597888
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/597888 | Process and system to make olefin epoxides | Jun 29, 2020 | Issued |
Array
(
[id] => 16360921
[patent_doc_number] => 20200317672
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS HAVING A HETEROBIARYL MOIETY, CONJUGATES THEREOF, AND METHODS AND USES THEREFOR
[patent_app_type] => utility
[patent_app_number] => 16/904337
[patent_app_country] => US
[patent_app_date] => 2020-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12845
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16904337
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/904337 | Toll-like receptor 7 (TLR7) agonists having a heterobiaryl moiety, conjugates thereof, and methods and uses therefor | Jun 16, 2020 | Issued |
Array
(
[id] => 18172682
[patent_doc_number] => 11572379
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-07
[patent_title] => Monomaleimide-functionalized platinum compounds for cancer therapy
[patent_app_type] => utility
[patent_app_number] => 16/904528
[patent_app_country] => US
[patent_app_date] => 2020-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 21624
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16904528
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/904528 | Monomaleimide-functionalized platinum compounds for cancer therapy | Jun 16, 2020 | Issued |
Array
(
[id] => 20343082
[patent_doc_number] => 12466804
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-11
[patent_title] => Cyclobutyl carboxylic acids as LPA antagonists
[patent_app_type] => utility
[patent_app_number] => 17/617611
[patent_app_country] => US
[patent_app_date] => 2020-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36731
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17617611
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/617611 | Cyclobutyl carboxylic acids as LPA antagonists | Jun 15, 2020 | Issued |
Array
(
[id] => 18101138
[patent_doc_number] => 11541004
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-03
[patent_title] => Method for treating or mitigating Parkinson's disease using nicotine inhaler or nicotine nasal spray
[patent_app_type] => utility
[patent_app_number] => 16/897780
[patent_app_country] => US
[patent_app_date] => 2020-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2812
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16897780
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/897780 | Method for treating or mitigating Parkinson's disease using nicotine inhaler or nicotine nasal spray | Jun 9, 2020 | Issued |
Array
(
[id] => 16328302
[patent_doc_number] => 20200299268
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-24
[patent_title] => SMALL MOLECULE INHIBITORS OF SHARED EPITOPE-CALRETICULIN INTERACTIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 16/896546
[patent_app_country] => US
[patent_app_date] => 2020-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10996
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16896546
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/896546 | Small molecule inhibitors of shared epitope-calreticulin interactions and methods of use | Jun 8, 2020 | Issued |
Array
(
[id] => 20187021
[patent_doc_number] => 12398126
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-26
[patent_title] => Process to synthesize 5-(3pyridyl)-2,2'-bithiophene(sensitizer)
[patent_app_type] => utility
[patent_app_number] => 17/615757
[patent_app_country] => US
[patent_app_date] => 2020-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17615757
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/615757 | Process to synthesize 5-(3pyridyl)-2,2'-bithiophene(sensitizer) | Jun 7, 2020 | Issued |
Array
(
[id] => 16326768
[patent_doc_number] => 20200297733
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-24
[patent_title] => BETA-LACTAMASE INHIBITORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/895033
[patent_app_country] => US
[patent_app_date] => 2020-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 75775
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16895033
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/895033 | BETA-LACTAMASE INHIBITORS AND USES THEREOF | Jun 7, 2020 | Abandoned |
Array
(
[id] => 16720010
[patent_doc_number] => 20210087157
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-25
[patent_title] => METHODS FOR PRODUCING 5-(HALOMETHYL)FURFURAL
[patent_app_type] => utility
[patent_app_number] => 16/894503
[patent_app_country] => US
[patent_app_date] => 2020-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23513
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16894503
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/894503 | Methods for producing 5-(halomethyl)furfural | Jun 4, 2020 | Issued |
Array
(
[id] => 20143887
[patent_doc_number] => 12378214
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-05
[patent_title] => 12-oxaspiro[5,5]undec-8-ene useful in fragrance compositions
[patent_app_type] => utility
[patent_app_number] => 17/615301
[patent_app_country] => US
[patent_app_date] => 2020-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17615301
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/615301 | 12-oxaspiro[5,5]undec-8-ene useful in fragrance compositions | Jun 2, 2020 | Issued |